Quantinno Capital Management LP Purchases 37,552 Shares of Integer Holdings Corporation $ITGR

Quantinno Capital Management LP lifted its holdings in Integer Holdings Corporation (NYSE:ITGR) by 93.4% in the first quarter, HoldingsChannel reports. The firm owned 77,757 shares of the medical equipment provider’s stock after purchasing an additional 37,552 shares during the quarter. Quantinno Capital Management LP’s holdings in Integer were worth $6,843,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Salomon & Ludwin LLC lifted its position in Integer by 46.8% during the fourth quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 118 shares during the last quarter. TD Private Client Wealth LLC increased its holdings in shares of Integer by 1,037.5% in the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after buying an additional 415 shares during the last quarter. Parkside Financial Bank & Trust raised its position in shares of Integer by 135.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after buying an additional 267 shares in the last quarter. Arax Advisory Partners lifted its holdings in shares of Integer by 2,489.5% in the 4th quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 473 shares during the last quarter. Finally, Farther Finance Advisors LLC lifted its stake in shares of Integer by 193.2% in the 4th quarter. Farther Finance Advisors LLC now owns 519 shares of the medical equipment provider’s stock valued at $41,000 after purchasing an additional 342 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on ITGR. Weiss Ratings restated a “hold (c)” rating on shares of Integer in a report on Thursday, June 18th. Zacks Research raised shares of Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th. Raymond James Financial cut shares of Integer from a “moderate buy” rating to a “hold” rating in a research report on Monday. KeyCorp downgraded shares of Integer from an “overweight” rating to a “sector weight” rating in a research note on Monday. Finally, HC Wainwright restated a “buy” rating on shares of Integer in a report on Friday, July 24th. One analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $109.86.

Integer Trading Down 0.1%

ITGR opened at $124.93 on Thursday. The stock has a market cap of $4.24 billion, a price-to-earnings ratio of 34.13, a P/E/G ratio of 2.98 and a beta of 0.61. The stock’s 50 day moving average price is $95.99 and its 200-day moving average price is $89.84. Integer Holdings Corporation has a one year low of $62.00 and a one year high of $125.54. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.38 by $0.22. Integer had a return on equity of 12.77% and a net margin of 6.97%.The firm had revenue of $464.11 million for the quarter, compared to the consensus estimate of $451.07 million. During the same period in the prior year, the business posted $1.55 earnings per share. The company’s revenue for the quarter was down 2.6% on a year-over-year basis. On average, equities analysts forecast that Integer Holdings Corporation will post 6.04 EPS for the current year.

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.